Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PALM2,Paralemmin-2,Inverse variance weighted,8,1.47 [1.13-1.91],0.00390058927470839,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,1.23 [1.07-1.43],0.00492345128232864,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,55,0.92 [0.87-0.98],0.00536238103746729,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.76 [0.62-0.93],0.00694003291139303,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.23 [1.05-1.43],0.00966441238394413,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.77 [0.63-0.94],0.00993608275083506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.79 [0.66-0.96],0.0144909658113678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.26 [1.04-1.51],0.0170787994757169,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,0.57 [0.35-0.92],0.0224946260556644,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,REN,Renin,Inverse variance weighted,4,1.31 [1.03-1.67],0.027491966776454,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.81 [0.67-0.98],0.0276926348326445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SCG2,Secretogranin-2,Wald ratio,1,4.5 [1.12-18],0.033505095886368,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,0.77 [0.6-0.98],0.035251827778676,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.1 [1-1.2],0.0393217349681621,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.34 [1.01-1.78],0.0456992907377848,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.65 [0.42-0.99],0.0467714812801233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,0.83 [0.68-1],0.0475748432707348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PLXNB2,Plexin-B2,Inverse variance weighted,27,0.93 [0.86-1],0.0490320985824856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RBP2,Retinol-binding protein 2,Wald ratio,1,2.93 [1-8.56],0.0492953878356129,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.66 [1-2.75],0.0493601292727275,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD46,Membrane cofactor protein,Wald ratio,1,2.07 [0.99-4.33],0.0538353947764817,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EDN1,Endothelin-1,Inverse variance weighted,3,1.32 [0.98-1.76],0.0659378385573852,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.58 [0.32-1.04],0.0669203395314239,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD83,CD83 antigen,Inverse variance weighted,5,1.35 [0.97-1.88],0.0724168786620609,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.71 [0.49-1.05],0.0834486264990849,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.41 [0.95-2.09],0.0920672355424565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.77 [0.56-1.05],0.09861510662379,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NPY,Pro-neuropeptide Y,Inverse variance weighted,3,0.67 [0.42-1.08],0.101382647452456,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.11 [0.98-1.27],0.111392920069228,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1.11 [0.97-1.26],0.118318757689893,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.84 [0.67-1.05],0.121246090522722,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,MUC13,Mucin-13,Inverse variance weighted,9,0.82 [0.63-1.06],0.127571941257404,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CHGB,Secretogranin-1,Inverse variance weighted,27,0.91 [0.8-1.03],0.128172285620967,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NFASC,Neurofascin,Inverse variance weighted,15,0.88 [0.76-1.04],0.128524081715012,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,1.45 [0.89-2.33],0.132252888484928,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,1.49 [0.89-2.51],0.132849440990284,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.77 [0.54-1.09],0.135706268290849,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SEPTIN8,Septin-8,Inverse variance weighted,2,1.43 [0.89-2.28],0.137794837512761,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,0.78 [0.56-1.09],0.147522094349417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.75 [0.51-1.11],0.15536064897197,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SPON2,Spondin-2,Inverse variance weighted,4,1.32 [0.89-1.95],0.167118541024081,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,0.95 [0.87-1.02],0.167241576463103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.24 [0.91-1.69],0.168770997064285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.37 [0.87-2.15],0.17017128004962,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ANXA5,Annexin A5,Inverse variance weighted,2,1.76 [0.78-3.95],0.173899927617265,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.12 [0.95-1.32],0.175016201653489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD27,CD27 antigen,Inverse variance weighted,9,1.14 [0.94-1.38],0.179772504276755,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.22 [0.91-1.63],0.181919098781481,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,3.43 [0.54-21.76],0.190410686974093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1.11 [0.95-1.29],0.191358539374702,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.2 [0.91-1.57],0.198929225371052,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.12 [0.94-1.34],0.208437035830954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PGF,Placenta growth factor,Inverse variance weighted,2,0.36 [0.07-1.78],0.208510606246158,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,UMOD,Uromodulin,Inverse variance weighted,29,0.94 [0.85-1.04],0.211367100183476,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.2 [0.9-1.61],0.213873085435839,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.49 [0.78-2.85],0.231627415648389,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1.15 [0.92-1.44],0.233097000610805,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,0.94 [0.84-1.04],0.2337067422516,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.36 [0.07-1.97],0.239983323340188,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.37 [0.07-1.94],0.240171102280088,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.89 [0.74-1.08],0.241952149573617,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.72 [0.41-1.26],0.247152137640047,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,0.91 [0.77-1.07],0.248593354961769,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,BSG,Basigin,Wald ratio,1,1.32 [0.82-2.1],0.250456238283667,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.72 [0.4-1.28],0.261125475831693,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.18 [0.88-1.59],0.263300673495186,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CFD,Complement factor D,Inverse variance weighted,11,1.18 [0.88-1.56],0.263990489302929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.77 [0.49-1.22],0.264317267593637,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,0.89 [0.73-1.09],0.266691265208876,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,0.89 [0.72-1.1],0.270159053582557,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PI3,Elafin,Inverse variance weighted,10,1.11 [0.92-1.35],0.274404762119175,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,1.2 [0.87-1.67],0.274450532233985,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.89 [0.71-1.1],0.274843224829945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.09 [0.93-1.28],0.278330898534445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,1.31 [0.8-2.15],0.280011472479819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.16 [0.89-1.51],0.283274606493186,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.06 [0.95-1.18],0.287641956102605,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.89 [0.72-1.11],0.297549257407681,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,50,1.04 [0.96-1.13],0.308809216723629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,KLK4,Kallikrein-4,Inverse variance weighted,17,1.08 [0.93-1.24],0.310460467814535,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,0.93 [0.8-1.07],0.310476947389105,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.07 [0.93-1.24],0.315151968603591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,1.1 [0.91-1.34],0.315743078036714,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,KLK11,Kallikrein-11,Inverse variance weighted,6,1.07 [0.93-1.23],0.334415200668856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.95 [0.86-1.05],0.336283710967282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CST3,Cystatin-C,Inverse variance weighted,10,1.1 [0.9-1.34],0.342437431068033,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.87 [0.66-1.16],0.342545540944458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FOLR1,Folate receptor alpha,Inverse variance weighted,5,0.78 [0.47-1.3],0.347791348254743,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.35 [0.7-2.58],0.369341358571128,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.86 [0.62-1.2],0.369793930529546,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.08 [0.91-1.28],0.372552439887168,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.2 [0.8-1.78],0.379669945747489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NECTIN4,Nectin-4,Inverse variance weighted,7,0.88 [0.67-1.16],0.380616599716335,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.15 [0.84-1.57],0.381985952760152,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.42 [0.65-3.1],0.383511026714906,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.1 [0.89-1.37],0.384650369284712,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.77 [0.42-1.4],0.386882017287074,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,0.93 [0.79-1.1],0.387570366038263,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CDH1,Cadherin-1,Wald ratio,1,0.54 [0.13-2.2],0.3880807972433,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.96 [0.86-1.06],0.399563507808739,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.1 [0.88-1.38],0.401073607929717,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.64 [0.51-5.24],0.405466494506471,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.96 [0.86-1.06],0.405818822885534,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.11 [0.87-1.41],0.412055521446736,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.15 [0.82-1.61],0.420330946571877,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1.2 [0.77-1.89],0.423480328384385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.65 [0.22-1.92],0.439362751612021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.05 [0.92-1.2],0.439676333740757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.07 [0.9-1.27],0.449963839405618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.18 [0.77-1.8],0.454897530578747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.43 [0.56-3.67],0.455366137706006,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CDH3,Cadherin-3,Inverse variance weighted,2,0.75 [0.35-1.61],0.459454892520741,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.06 [0.91-1.23],0.460474896053729,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,AMBP,Protein AMBP,Inverse variance weighted,3,0.76 [0.37-1.57],0.462948326603295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.08 [0.87-1.34],0.463483822526519,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1.14 [0.8-1.61],0.466090562307303,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,APOA4,Apolipoprotein A-IV,Wald ratio,1,1.71 [0.39-7.37],0.474432425959829,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.46 [0.51-4.14],0.478595234406475,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,0.82 [0.48-1.42],0.481052146572993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CHGA,Chromogranin-A,Inverse variance weighted,3,1.12 [0.81-1.56],0.495322700984844,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FAM3B,Protein FAM3B,Inverse variance weighted,18,1.04 [0.93-1.16],0.501236892645333,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.88 [0.61-1.27],0.50145180679071,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD48,CD48 antigen,Inverse variance weighted,18,1.04 [0.92-1.17],0.502133600731148,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.86 [0.56-1.33],0.504070670824201,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,0.65 [0.18-2.38],0.512789414188332,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,1.08 [0.86-1.36],0.514735832509,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD302,CD302 antigen,Inverse variance weighted,9,1.08 [0.86-1.35],0.519566987573243,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.04 [0.92-1.18],0.520177516326305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.08 [0.84-1.39],0.533131163188828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,0.96 [0.85-1.09],0.535871742735219,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.91 [0.69-1.22],0.536280429425836,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,MDK,Midkine,Inverse variance weighted,4,1.28 [0.58-2.83],0.54025583010941,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,0.96 [0.85-1.09],0.543728555026573,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.84 [0.49-1.46],0.544250728414,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,C7,Complement component C7,Inverse variance weighted,38,1.03 [0.95-1.11],0.546893969379448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,1.08 [0.83-1.42],0.554399620167905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.04 [0.9-1.21],0.563238509547506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.02 [0.95-1.11],0.56347263956643,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,0.88 [0.57-1.35],0.564568733305134,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.04 [0.91-1.18],0.571330384886821,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.05 [0.88-1.24],0.586787133609772,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.18 [0.64-2.18],0.590250479897171,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.97 [0.86-1.09],0.591085359484388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,4,0.83 [0.42-1.63],0.593197779186472,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DSC2,Desmocollin-2,Inverse variance weighted,9,0.94 [0.76-1.17],0.600433184730055,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.24 [0.56-2.75],0.600457486909279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.08 [0.81-1.44],0.6015543734211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.09 [0.78-1.52],0.606420532027107,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.74 [0.22-2.49],0.623431708216085,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.83 [0.38-1.81],0.633915955260176,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TFF3,Trefoil factor 3,Inverse variance weighted,5,0.92 [0.67-1.28],0.635786889733038,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.12 [0.71-1.76],0.638056179892565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.14 [0.65-2],0.638899973895734,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.96 [0.8-1.14],0.642080878992423,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,1.07 [0.8-1.43],0.646535828281064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,0.97 [0.83-1.12],0.654015105584291,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LGALS9,Galectin-9,Inverse variance weighted,26,0.97 [0.84-1.11],0.654300801075062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,0.97 [0.86-1.1],0.655613671556037,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.11 [0.7-1.74],0.658887633764565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,0.94 [0.72-1.23],0.662634653922331,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CCN3,CCN family member 3,Inverse variance weighted,19,1.05 [0.85-1.28],0.662906994049399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.05 [0.83-1.33],0.664915495768282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,0.97 [0.86-1.1],0.673683401849877,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.07 [0.76-1.49],0.701632219138343,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD276,CD276 antigen,Inverse variance weighted,20,0.98 [0.88-1.09],0.709189090548325,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,1.13 [0.58-2.21],0.7117595254949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.86 [0.39-1.89],0.711952552100149,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,MMP7,Matrilysin,Inverse variance weighted,13,0.95 [0.73-1.24],0.713538461278443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.08 [0.73-1.6],0.715371292772297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.05 [0.8-1.39],0.721410186249433,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,1.13 [0.56-2.3],0.726401758959624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,13,1.04 [0.84-1.28],0.733878128305848,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.96 [0.78-1.19],0.736566014414756,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.78 [0.17-3.51],0.74472038451284,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.96 [0.74-1.24],0.747437817302454,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PRELP,Prolargin,Inverse variance weighted,9,1.03 [0.85-1.25],0.750020978770327,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,0.98 [0.88-1.09],0.750823905537212,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CCN5,CCN family member 5,Inverse variance weighted,8,0.92 [0.55-1.54],0.759057238647828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.03 [0.85-1.25],0.762393915859251,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,0.96 [0.72-1.28],0.766161231854984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.95 [0.67-1.35],0.76825702609587,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.9 [0.46-1.77],0.769640342586917,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,OGN,Mimecan,Inverse variance weighted,30,0.98 [0.84-1.13],0.769976698336509,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.95 [0.67-1.35],0.771540264551558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SPON1,Spondin-1,Inverse variance weighted,21,1.02 [0.87-1.2],0.774553539799113,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.02 [0.91-1.13],0.776110398851957,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,0.99 [0.89-1.09],0.777526579760699,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1.24 [0.28-5.52],0.778523519471677,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.03 [0.84-1.25],0.78538748324984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.07 [0.67-1.7],0.788005743076614,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.94 [0.57-1.52],0.790150329896998,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.82 [0.17-3.83],0.79581801198593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,1.02 [0.88-1.17],0.797615580003566,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,0.95 [0.65-1.4],0.808465121554912,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CCN4,CCN family member 4,Inverse variance weighted,27,0.99 [0.88-1.11],0.812332584625116,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PRSS8,Prostasin,Inverse variance weighted,5,0.95 [0.6-1.49],0.812990586932865,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,VWC2,Brorin,Inverse variance weighted,22,1.02 [0.84-1.25],0.813941517256045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,COLEC12,Collectin-12,Inverse variance weighted,11,0.97 [0.76-1.24],0.81683049970783,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.97 [0.74-1.27],0.822534311916212,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.98 [0.85-1.14],0.82266519258155,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,INHBB,Inhibin beta B chain,Inverse variance weighted,10,1.02 [0.85-1.23],0.827810585827759,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,17,0.99 [0.89-1.1],0.836291830170496,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GUCA2A,Guanylin,Inverse variance weighted,9,1.03 [0.77-1.39],0.843115440515157,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.03 [0.79-1.33],0.847275627411933,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.95 [0.55-1.65],0.855651853250988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SHISA5,Protein shisa-5,Inverse variance weighted,5,1.06 [0.56-2.01],0.857167344920499,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.98 [0.82-1.18],0.857831194289527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LGALS4,Galectin-4,Inverse variance weighted,4,1.04 [0.69-1.56],0.863320983982251,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,0.99 [0.89-1.11],0.870149249963009,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.99 [0.86-1.14],0.872980550464876,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.1 [0.35-3.39],0.87375440021614,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RSPO3,R-spondin-3,Inverse variance weighted,6,0.97 [0.69-1.37],0.874248188268324,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.96 [0.58-1.58],0.8748212130456,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.97 [0.66-1.42],0.878015502806604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.99 [0.87-1.13],0.883155137374327,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,1.06 [0.46-2.49],0.885037887409388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,STC1,Stanniocalcin-1,Inverse variance weighted,2,0.94 [0.36-2.46],0.891734565257207,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.01 [0.86-1.19],0.904846236126815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PSAP,Prosaposin,Inverse variance weighted,5,1.02 [0.76-1.36],0.905275899193999,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.11 [0.17-7.36],0.913053307535995,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,0.92 [0.16-5.4],0.930147330103126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,AGRN,Agrin,Inverse variance weighted,17,1.01 [0.81-1.26],0.931525288101609,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.97 [0.41-2.27],0.935176832839471,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,0.99 [0.88-1.13],0.936036955749639,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1 [0.89-1.13],0.936486651684969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1 [0.93-1.08],0.937697722153735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LAYN,Layilin,Inverse variance weighted,20,0.99 [0.82-1.21],0.9421923021002,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,AREG,Amphiregulin,Inverse variance weighted,3,0.97 [0.37-2.54],0.943107275685627,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.01 [0.74-1.38],0.951790050596924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1 [0.91-1.11],0.953556570314284,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CX3CL1,Fractalkine,Inverse variance weighted,9,1.01 [0.75-1.35],0.954725443070856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,22,1 [0.89-1.13],0.955511013303069,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.99 [0.62-1.57],0.95748062052015,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD160,CD160 antigen,Inverse variance weighted,11,1 [0.82-1.21],0.962234303143436,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.02 [0.44-2.38],0.964542263361071,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.99 [0.65-1.51],0.969855547134242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.98 [0.3-3.18],0.975962978420886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1 [0.84-1.2],0.99058295708984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NECTIN2,Nectin-2,Inverse variance weighted,5,1 [0.81-1.23],0.991876829213514,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1 [0.9-1.11],0.998822515527792,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.34 [0.17-0.66],0.00156013867209969,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PALM2,Paralemmin-2,Inverse variance weighted,9,1.49 [1.15-1.93],0.00259928361772997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.63 [0.47-0.85],0.00279961071623593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.28 [0.12-0.65],0.00284929962994751,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.69 [1.15-2.48],0.00743103409824654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.71 [0.55-0.91],0.00831002768993703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,WNT9A,Protein Wnt-9a,Wald ratio,1,11.38 [1.8-71.92],0.00972882368355259,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NECTIN2,Nectin-2,Inverse variance weighted,3,6.63 [1.43-30.8],0.0157460152203739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.47 [0.24-0.9],0.023378409024532,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,2.41 [1.09-5.36],0.0301684961652671,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.98 [1.05-3.76],0.0353520548764327,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.44 [0.21-0.95],0.0368667415747179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.72 [0.53-0.98],0.0383004221688792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,0.44 [0.2-0.98],0.0449847113299344,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,43,1.12 [1-1.25],0.0464965275700632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.7 [0.49-1.01],0.0538988421342304,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,C7,Complement component C7,Inverse variance weighted,26,1.17 [0.99-1.37],0.0609686083650514,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.45 [0.2-1.04],0.0610297992946226,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,MDK,Midkine,Inverse variance weighted,14,1.39 [0.98-1.96],0.0618306526980515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.2 [0.99-1.45],0.0622187864882317,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.7 [0.48-1.02],0.06494061560284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.41 [0.97-2.05],0.0707210111211147,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.22 [0.98-1.52],0.075280685981482,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PGF,Placenta growth factor,Inverse variance weighted,5,0.56 [0.29-1.07],0.0770985294969769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1.13 [0.98-1.29],0.0889140137168203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.75 [0.53-1.05],0.095237819784875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.59 [0.92-2.75],0.0980306197429486,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,MUC13,Mucin-13,Inverse variance weighted,3,0.47 [0.2-1.15],0.0996316719452695,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD302,CD302 antigen,Inverse variance weighted,11,0.77 [0.56-1.05],0.100091186643217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,2.21 [0.85-5.76],0.104140134127873,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,UMOD,Uromodulin,Inverse variance weighted,34,0.81 [0.62-1.05],0.105553858397037,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.46 [0.91-2.36],0.11690065783966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.73 [0.49-1.09],0.126237993205938,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,XG,Glycoprotein Xg,Inverse variance weighted,2,0.43 [0.14-1.29],0.133946467063554,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.11 [0.97-1.28],0.140165889229236,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.24 [0.93-1.66],0.146219148415913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.86 [0.8-4.35],0.150117197041838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.22 [0.93-1.6],0.160341200610164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LGALS4,Galectin-4,Inverse variance weighted,15,0.87 [0.71-1.06],0.162743709069442,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,3.05 [0.61-15.16],0.173436094799112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,0.71 [0.44-1.16],0.175151692035148,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.6 [0.29-1.26],0.176591290552515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.1 [0.96-1.26],0.179236214418804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.79 [0.57-1.11],0.180865790065295,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.86 [0.7-1.07],0.18434518460888,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.71 [0.42-1.18],0.186245503849928,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD83,CD83 antigen,Inverse variance weighted,14,0.78 [0.53-1.13],0.186662516706226,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.5 [0.82-2.76],0.192353273606283,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,REN,Renin,Inverse variance weighted,8,1.36 [0.85-2.18],0.202125298150595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.77 [0.51-1.16],0.208367616189078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD46,Membrane cofactor protein,Inverse variance weighted,2,1.67 [0.75-3.75],0.212238203149073,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CKB,Creatine kinase B-type,Inverse variance weighted,11,1.44 [0.81-2.55],0.216384611740439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.7 [0.39-1.24],0.21668875686209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.3 [0.86-1.97],0.220555610330732,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GUCA2A,Guanylin,Inverse variance weighted,7,0.76 [0.49-1.18],0.226041842255255,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.62 [0.28-1.36],0.233453984242212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.56 [0.21-1.49],0.242249331286462,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,7,0.73 [0.43-1.24],0.246387757650369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,0.73 [0.43-1.25],0.252111261447171,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,0.9 [0.75-1.08],0.254891666453923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LAYN,Layilin,Inverse variance weighted,3,1.71 [0.68-4.35],0.256561399312505,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,2.24 [0.55-9.18],0.263173560049918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.84 [0.62-1.14],0.265264126797727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.71 [0.38-1.31],0.275063864104692,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NECTIN4,Nectin-4,Inverse variance weighted,4,2.21 [0.52-9.32],0.279490187852346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,1.19 [0.87-1.62],0.280273817898358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.47 [0.12-1.86],0.282327023285945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,1.29 [0.8-2.09],0.292709821837942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.85 [0.62-1.16],0.295197034991984,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,6,0.7 [0.36-1.37],0.301301900546276,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD276,CD276 antigen,Inverse variance weighted,24,0.88 [0.69-1.12],0.302388227426274,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.53 [0.68-3.46],0.307187129359105,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,1.6 [0.64-4.02],0.318327045583057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.05 [0.95-1.17],0.327565004058298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.57 [0.19-1.77],0.333133921422738,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.28 [0.77-2.11],0.338897358008663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.42 [0.69-2.93],0.341913168430513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DCN,Decorin,Inverse variance weighted,2,0.58 [0.18-1.8],0.342000571613802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.32 [0.74-2.36],0.351049300128584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,AOC3,Membrane primary amine oxidase,Inverse variance weighted,34,0.95 [0.85-1.06],0.353242685562724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.37 [0.7-2.67],0.355667161022759,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD48,CD48 antigen,Inverse variance weighted,14,0.79 [0.49-1.3],0.355711052888042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.22 [0.8-1.86],0.365974885197757,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.35 [0.7-2.62],0.369990420848978,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,MMP7,Matrilysin,Wald ratio,1,1.31 [0.72-2.39],0.370218031485165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RSPO3,R-spondin-3,Inverse variance weighted,5,1.31 [0.72-2.38],0.371944235055621,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.77 [0.49-6.32],0.380776951501158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,APOA4,Apolipoprotein A-IV,Inverse variance weighted,4,0.61 [0.2-1.83],0.380818527074057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.27 [0.74-2.18],0.382534992307516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,0.92 [0.77-1.11],0.386559684974749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.89 [0.68-1.17],0.398900356715968,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,COLEC12,Collectin-12,Inverse variance weighted,3,1.52 [0.56-4.14],0.415006087556001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.95 [0.83-1.08],0.416253008764674,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.15 [0.81-1.64],0.425737865910733,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,1.41 [0.6-3.33],0.431198143437097,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.87 [0.6-1.24],0.433352822396739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.65 [0.22-1.92],0.439362751612021,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.93 [0.78-1.12],0.444564315287047,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SPON2,Spondin-2,Inverse variance weighted,3,1.41 [0.58-3.4],0.449411456279716,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,KLK11,Kallikrein-11,Inverse variance weighted,13,1.14 [0.82-1.58],0.452443278674409,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.1 [0.86-1.41],0.452634438212152,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.19 [0.75-1.86],0.459440248331384,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,AGRN,Agrin,Inverse variance weighted,14,1.16 [0.78-1.74],0.460774761417744,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CDH1,Cadherin-1,Inverse variance weighted,16,1.09 [0.86-1.4],0.464259019271037,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.21 [0.73-2],0.469765660237058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.33 [0.61-2.9],0.478931156713945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CFD,Complement factor D,Wald ratio,1,1.61 [0.41-6.33],0.494463032077545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,BSG,Basigin,Inverse variance weighted,6,0.82 [0.47-1.46],0.503121038677955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,1.13 [0.79-1.62],0.505482399473569,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PRELP,Prolargin,Inverse variance weighted,5,0.75 [0.32-1.74],0.505551792737776,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.91 [0.68-1.21],0.507571230714317,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.09 [0.84-1.41],0.516054182958563,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.17 [0.73-1.86],0.516303855025455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PI3,Elafin,Inverse variance weighted,18,1.06 [0.89-1.27],0.527989581270731,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LGALS9,Galectin-9,Inverse variance weighted,36,0.96 [0.84-1.09],0.531988645664519,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.15 [0.73-1.82],0.533969802073581,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.97 [0.86-1.08],0.535080299575623,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CHGA,Chromogranin-A,Inverse variance weighted,5,1.16 [0.72-1.89],0.53549564360879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.17 [0.71-1.91],0.536777593836374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,0.88 [0.59-1.33],0.55252336858681,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,1.11 [0.77-1.61],0.560931209060709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,1.35 [0.48-3.78],0.562810031995481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.91 [0.67-1.25],0.569658726262558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PRSS8,Prostasin,Inverse variance weighted,14,1.15 [0.71-1.87],0.574253623227883,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.17 [0.67-2.03],0.579887890574933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,AMBP,Protein AMBP,Inverse variance weighted,5,0.85 [0.47-1.54],0.58397542195824,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,1.08 [0.82-1.43],0.587080919749072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CCN3,CCN family member 3,Inverse variance weighted,17,0.95 [0.78-1.15],0.601363090166963,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.15 [0.67-2],0.605386808097215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.75 [0.24-2.28],0.60763506667202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.16 [0.66-2.02],0.608390218326009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PSAP,Prosaposin,Inverse variance weighted,13,0.95 [0.76-1.17],0.610897217735153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.91 [0.61-1.34],0.617060944144367,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,0.97 [0.86-1.09],0.620553769572106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.7 [0.17-2.94],0.627627324760883,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.97 [0.86-1.1],0.627805736137778,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.32 [0.43-4.07],0.630844100643166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.72 [0.19-2.8],0.635383414314014,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.23 [0.52-2.94],0.639386661247842,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CX3CL1,Fractalkine,Inverse variance weighted,12,0.91 [0.62-1.34],0.643599550525928,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.96 [0.81-1.14],0.647421830732264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.45 [0.28-7.46],0.659160527794549,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD27,CD27 antigen,Inverse variance weighted,9,1.12 [0.66-1.91],0.668776420957149,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SPON1,Spondin-1,Inverse variance weighted,4,0.86 [0.44-1.7],0.673553433015577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CST3,Cystatin-C,Inverse variance weighted,3,1.44 [0.27-7.71],0.673697448799041,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.96 [0.81-1.15],0.674744800211378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.17 [0.56-2.44],0.676227688033894,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.18 [0.55-2.52],0.67743825389551,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.84 [0.36-1.95],0.677713439589432,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SCG2,Secretogranin-2,Inverse variance weighted,2,0.84 [0.37-1.91],0.678028170026089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.65 [0.09-4.98],0.679088484874504,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.19 [0.52-2.71],0.682085085352137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,OGN,Mimecan,Inverse variance weighted,37,0.97 [0.85-1.11],0.683216139306848,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,0.94 [0.68-1.29],0.691166464027774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.86 [0.41-1.83],0.697516346017289,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.1 [0.67-1.83],0.699212695002684,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.14 [0.58-2.25],0.700347001377131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.1 [0.67-1.81],0.701377497697168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1.09 [0.71-1.66],0.701476968914989,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.11 [0.65-1.88],0.702944256513666,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,KLK4,Kallikrein-4,Inverse variance weighted,5,0.85 [0.38-1.94],0.705288686097033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,0.95 [0.75-1.22],0.707254709279643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,AREG,Amphiregulin,Inverse variance weighted,5,0.84 [0.32-2.15],0.709536486772197,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.86 [0.37-1.97],0.715272778093588,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,0.91 [0.55-1.51],0.71562141677162,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.15 [0.54-2.44],0.715874692219607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.04 [0.86-1.25],0.71683989498795,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.91 [0.56-1.49],0.722115550039889,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.9 [0.49-1.65],0.725516282951993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.98 [0.87-1.1],0.726564452214451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NFASC,Neurofascin,Inverse variance weighted,6,0.9 [0.49-1.68],0.745820979254292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,1.19 [0.41-3.47],0.750323783918945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,0.92 [0.54-1.57],0.751215496808833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.17 [0.43-3.18],0.75456389701707,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SEPTIN8,Septin-8,Inverse variance weighted,4,0.91 [0.5-1.65],0.758387038118243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.32 [0.21-8.27],0.765868856035799,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.11 [0.55-2.26],0.76742661482438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,1.08 [0.65-1.81],0.767673461394448,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,1.22 [0.31-4.77],0.769887972874699,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.95 [0.67-1.34],0.771344223522919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.92 [0.54-1.59],0.772014267251788,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.1 [0.58-2.06],0.774309698266922,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.04 [0.81-1.32],0.780490493510685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,13,0.95 [0.67-1.36],0.780822906682206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,0.89 [0.39-2.02],0.782940195497084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.07 [0.67-1.72],0.783139385066135,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.91 [0.47-1.77],0.784000677615105,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.95 [0.63-1.42],0.786060830925809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.92 [0.49-1.72],0.792472510096803,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,1.03 [0.84-1.26],0.794784256893904,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,14,1.07 [0.63-1.82],0.797974515708086,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,1.02 [0.88-1.19],0.80385911858745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.07 [0.6-1.91],0.805734811659419,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.03 [0.83-1.26],0.809798710796601,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD160,CD160 antigen,Inverse variance weighted,24,1.03 [0.81-1.31],0.816364484960158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.04 [0.73-1.5],0.81930348613117,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.03 [0.82-1.29],0.822586504445692,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.94 [0.53-1.66],0.824448513166691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.91 [0.37-2.22],0.835880230858498,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,STC1,Stanniocalcin-1,Inverse variance weighted,9,0.96 [0.62-1.47],0.841321566867709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CCN5,CCN family member 5,Inverse variance weighted,12,0.98 [0.78-1.22],0.847303325739716,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.09 [0.41-2.9],0.860035335236651,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.04 [0.64-1.71],0.861157717491503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,0.96 [0.58-1.58],0.86583565114557,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,0.96 [0.61-1.52],0.869253327406401,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.08 [0.44-2.61],0.871003516705204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.95 [0.52-1.74],0.874058492620096,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.93 [0.38-2.3],0.875077162046393,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.07 [0.47-2.41],0.876567618378774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.96 [0.55-1.66],0.876675763615353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.85 [0.1-7.02],0.880314016780821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CHGB,Secretogranin-1,Inverse variance weighted,7,0.94 [0.39-2.24],0.881825507510709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,31,1.02 [0.81-1.27],0.884669404751728,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PLXNB2,Plexin-B2,Inverse variance weighted,12,1.03 [0.68-1.57],0.88509667405131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,0.92 [0.29-2.99],0.89502644856881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,0.98 [0.7-1.36],0.898016847466386,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.03 [0.64-1.66],0.900292804794705,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.93 [0.28-3.06],0.903964148732383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.02 [0.76-1.36],0.907373621683045,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1.02 [0.74-1.41],0.907411251103259,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.03 [0.64-1.65],0.910262667722904,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,0.98 [0.65-1.47],0.911470609075827,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.9 [0.15-5.5],0.912963816854741,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.03 [0.62-1.71],0.91597927978753,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,1.07 [0.32-3.6],0.917513042797545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,VWC2,Brorin,Inverse variance weighted,12,0.98 [0.64-1.49],0.921970381555879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CCN4,CCN family member 4,Inverse variance weighted,29,0.99 [0.84-1.17],0.931489365750446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.01 [0.81-1.27],0.932137493585882,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,GDF15,Growth/differentiation factor 15,Wald ratio,1,1.08 [0.16-7.39],0.938366020719635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,1.01 [0.88-1.15],0.938399183036893,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1 [0.93-1.09],0.941933961216293,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DSC2,Desmocollin-2,Inverse variance weighted,16,1.01 [0.83-1.22],0.944154667405273,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,1.03 [0.44-2.4],0.945109320910134,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.99 [0.8-1.23],0.946473507375233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.97 [0.42-2.23],0.950646411698002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.97 [0.33-2.82],0.953502683369834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.01 [0.78-1.31],0.954909642074096,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.06 [0.08-14.38],0.963977053563704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,0.99 [0.69-1.43],0.964960924649913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1 [0.82-1.22],0.967982846543211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.98 [0.31-3.11],0.973924186636195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,TFF3,Trefoil factor 3,Inverse variance weighted,10,1 [0.74-1.35],0.976269462756162,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.99 [0.52-1.9],0.979594984848446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,CDH3,Cadherin-3,Inverse variance weighted,10,1 [0.69-1.47],0.980786825744064,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1 [0.6-1.68],0.987007169402519,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,NPY,Pro-neuropeptide Y,Inverse variance weighted,15,1 [0.73-1.37],0.996705050455054,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1 [0.58-1.71],0.997709521175738,trans
